Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$24k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
6.8% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
7
users have followed this narrative
New
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
2.0% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
11
users have liked this narrative
1
users have commented on this narrative
17
users have followed this narrative
8 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.9% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
12
users have liked this narrative
4
users have commented on this narrative
12
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
47.4% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Chemring Group
AN
AnalystLowTarget
Consensus Narrative from 6 Analysts
US And UK Political Shifts Will Threaten Defense Contracts
Key Takeaways Heavy dependence on government defense spending and limited diversification exposes Chemring to political, regulatory, and technological risks that could hinder growth and profitability. Heightened ESG scrutiny and evolving contract structures may pressure margins, increasing compliance costs while masking underlying challenges in recurring profit generation.
View narrative
UK£4.90
FV
7.8% overvalued
intrinsic discount
8.79%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
18 days ago
author updated this narrative
CEMEX. de
AN
AnalystLowTarget
Consensus Narrative from 7 Analysts
Tightening Climate Regulation And Volatile FX Will Erode Value
Key Takeaways Tightening global climate policies and decarbonization efforts are likely to increase costs and reduce profitability for traditional cement operations. Rising competition from alternative materials and high debt could limit growth, sustainability progress, and long-term market share.
View narrative
Mex$14.99
FV
8.1% overvalued
intrinsic discount
2.37%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
18 days ago
author updated this narrative
PolyNovo
AN
AnalystLowTarget
Consensus Narrative from 9 Analysts
Global Cost Pressures And Regulatory Risks Will Cripple Future Prospects
Key Takeaways Mounting cost pressures, regulatory hurdles, and supply chain risks threaten profitability and growth despite ongoing expansion and innovation efforts. Growing competition and limited diversification beyond the core platform may erode market share and lead to volatile revenue and earnings.
View narrative
AU$1.15
FV
2.2% undervalued
intrinsic discount
20.39%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
18 days ago
author updated this narrative
PCBL Chemical
AN
AnalystLowTarget
Consensus Narrative from 10 Analysts
Carbon Reliance Will Shrink Margins Amid EV And Excess Supply
Key Takeaways Overdependence on traditional carbon black faces rising threats from decarbonization, alternative fillers, and recycled materials, risking market share and profitability. Regulatory pressures and persistent global overcapacity intensify cost, compliance, and price competition challenges, jeopardizing margin stability and expansion returns.
View narrative
₹394.00
FV
0.2% undervalued
intrinsic discount
7.48%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
18 days ago
author updated this narrative
CRISIL
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Digital Evolution And Compliance Challenges Will Reshape Market Dynamics
Key Takeaways Revenue and margin growth face risks from temporary factors, market normalization, automation-driven commoditization, and mounting regulatory compliance costs. New competition in analytics, advisory, and ESG ratings could undermine market share and limit long-term earnings expansion.
View narrative
₹4.93k
FV
10.3% overvalued
intrinsic discount
11.25%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
Updated
narrative
Prysmian
AN
AnalystConsensusTarget
Consensus Narrative from 18 Analysts
US Electrification And Grid Modernization Will Transform Infrastructure
Key Takeaways Accelerating investment trends, regulatory advantages, and product innovation are driving strong growth, margin expansion, and enhanced profitability for Prysmian in key markets. Strategic acquisitions and a premium, ESG-focused product mix position the company for sustained competitive advantage and resilient returns on capital.
View narrative
€73.93
FV
3.2% overvalued
intrinsic discount
5.43%
Revenue growth p.a.
Set Fair Value
2
users have liked this narrative
0
users have commented on this narrative
20
users have followed this narrative
6 days ago
author updated this narrative
Fortress Biotech
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
FDA Approval Will Open $1 Billion Dermatology Market
Key Takeaways Emrosi's successful launch and growing market adoption are expected to drive significant revenue growth, improved operating leverage, and expanding net margins. Strategic international out-licensing could deliver non-dilutive income, strengthen cash flow, and support global expansion without requiring additional capital.
View narrative
US$8.00
FV
72.6% undervalued
intrinsic discount
57.80%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
8
users have followed this narrative
Updated
narrative
Sonic Automotive
AN
AnalystConsensusTarget
Consensus Narrative from 9 Analysts
US Auto Trends Will Fuel Expansion In Fixed Operations
Key Takeaways Expansion of EchoPark and a focus on high-growth segments drive stronger margins and position the company for earnings growth as used car demand rises. Strategic optimization of dealership footprint and investment in digital operations enhance efficiency, recurring revenue, and adaptability to evolving market conditions.
View narrative
US$81.00
FV
1.3% undervalued
intrinsic discount
6.04%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
6 days ago
author updated this narrative
Jadestone Energy
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Akatara And Vietnam Gas Projects Will Deliver Robust Performance
Key Takeaways Operational outperformance, disciplined cost management, and asset sales are strengthening cash flow, margins, and enabling increased shareholder returns. New project developments and drilling programs ensure strong long-term growth opportunities and future reserves in the Asia-Pacific region.
View narrative
UK£0.61
FV
67.8% undervalued
intrinsic discount
13.29%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
5 days ago
author updated this narrative
Value any company in seconds
Popular companies